Research Projects & Grants

For Profit Organization

  • All to target trial lantus® (insulin glargine) with stepwise addition of APIDRA® (insulin glulisine) or Lantus with one injection of Apidra vs. a twice-daily premixed insulin regimen (Novolog® mix 70/30™) in adult subjects with type 2 diabetes failing dual or triple therapy with oral agents: a 64-week, multi-center, randomized, parallel, open-label clinical study. Protocol No. HMR 1964A/3515, Role: Investigator, Sanofi-Synthelabo Pharmaceuticals, (05/2008 - 05/2009) Status: Completed
  • An evaluation of six-day subcutaneous glucose sensor performance in subjects with type 1 diabetes mellitus, Role: Investigator, Medtronic, Inc., (10/2007 - 10/2008) Status: Completed
  • A multicenter, randomized, double-blind, active controlled study to compare the effect of 24 weeks treatment with vildagliptin 100 mg qd or metformin 1500 mg daily in elderly drug naïve patients with type 2 diabetes LAF237/vildagliptin Protocol number CLAF237A2398, Role: Investigator, Novartis Pharmaceuticals Corporation, (08/2007 - 08/2008) Status: Completed
  • Outpatient intensive cardiovascular disease secondary prevention and diabetes management program, Role: Investigator, GlaxoSmithKline, (02/2007 - 01/2008) Status: Completed
  • Pilot study to identify effective methods of training pump naive subjects to use the paradigm® 722 system and to describe clinical effectiveness compared to subjects continuing with multiple dose injections (MDI) of insulin (STAR2), Role: Investigator, Medtronic, Inc., (10/2005 - 10/2006) Status: Completed
  • Feasibility Study with Personalized Closed Loop (PCL), Role: Investigator, Medtronic, Inc., Status: Completed

Internal

  • A clinical work systems analysis of Diabetes co-management in hospitalized patients with continuous subcutaneous insulin infusion (CSII), Role: Investigator, LLU Dept. of Medicine, (06/2020) Status: Approved
  • A quality improvement project to compare the efficacy of multiple daily injections to continous subcutaneous insulin infusion in controlling blood glucose levels in type 1 Diabetes and to further compare glucose control between a community CS II program to a tertiary center CS II program, Role: Investigator, LLU Dept. of Medicine, (10/2003 - 10/2004) Status: Completed
  • The efficacy of the dual wave bolus feature in continous subcutaneous insulin infusion for controlling postprandial blood glucose in type 1 diabetes, Role: Investigator, LLU School of Medicine, Status: Completed